Covid “vaccine” from AstraZeneca found to increase risk of Guillain-Barré and other neurological conditions

The Trojan horse delivery system utilized in AstraZeneca’s Wuhan coronavirus (Covid-19) “vaccine” appears to be responsible for an increase in rates of Guillain-Barré syndrome (GBS) and other neurological problems, new research has revealed. Scientists from University College London (London’s Global University) says cases of GBS in the first two to four weeks following injection with the AstraZeneca shot … Continue reading Covid “vaccine” from AstraZeneca found to increase risk of Guillain-Barré and other neurological conditions

J&J vaccine may cause Guillain-Barré Syndrome, warns FDA

  The Food and Drug Administration (FDA) states that Guillain-Barré Syndrome (GBS) is a potential adverse effect of the Johnson & Johnson COVID-19 vaccine. According to the agency, there have been 100 reports of the rare but serious neurological disorder, following vaccination with said vaccine as of July 13. GBS causes inflammation of the nerves which can lead to sudden muscle weakness and … Continue reading J&J vaccine may cause Guillain-Barré Syndrome, warns FDA